EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress
Ruishan Zhang(China Medical University), Hong Xu(China Medical University)
Cited by 3
Related Papers
Germline mutations in 40 cancer susceptibility genes among <scp>C</scp>hinese patients with high hereditary risk breast cancer
|International Journal of Cancer|2018|61
EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress
|Cancer Cell International|2020|28